Organization | Diabeteszentrum Bad Lauterberg

Diabeteszentrum Bad Lauterberg Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Founded: Bad Lauterberg Germany (1968)

Organization Overview

First Clinical Trial

2004

NCT02673554

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Alternative names

Diabeteszentrum Bad Lauterberg, Germany | Diabeteszentrum Bad Lauterberg im Harz

Active Ingredients

Drugs in Phase 4 Trials (1)

exendin (9-39) (1 trial)

Drugs in Phase 3 Trials (4)

dapagliflozin (farxiga) (1 trial)

glipizide (glucotrol) (1 trial)

liraglutide (victoza) (1 trial)

sitagliptin (januvia) (4 trials)

Drugs in Phase 1 Trials (3)

gastric inhibitory polypeptide (1 trial)

glucose (1 trial)

vildagliptin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 8